Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2007
11/29/2007US20070275943 Method and Composition for Treatment or Prophylaxis of Amyloidosis Disorders
11/29/2007US20070275928 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
11/29/2007US20070275893 Compositions for enhanced epithelial permeation of peptide yy for treating obesity
11/29/2007US20070275879 Use of Ulinastatin and Its Pharmaceutical Composition for Treating Severe Acute Respiratory Syndrome
11/29/2007US20070275853 Solid Products with Improved Stability and Method for Producing the Same
11/29/2007US20070275235 Hydrogel has a Cylinder Centrifuge Retention Capacity of at least 10 g/g; elastomeric coating is non-breaking when the hydrogel is swollen to equilibrium in 0.9% saline solution; superabsorbers
11/29/2007US20070275118 Hot Liquid Fiber Product
11/29/2007US20070275083 ameliorating chronic renal insufficiency, hypertension, atherosclerosis, and chronic congestive heart failure
11/29/2007US20070275082 Preparation Method for Sustained Release Microspheres Using a Dual-Feed Nozzle
11/29/2007US20070275081 Aqueous Dispersion and Its Use
11/29/2007US20070275080 Polymer-Based Microstructures
11/29/2007US20070275079 Antigen-Containing Microspheres for the Treatment of Allergies
11/29/2007US20070275078 Microcapsules for the Administration of Active Ingredients
11/29/2007US20070275077 Wound compress
11/29/2007US20070275076 Method For The Production Of Porous Particles
11/29/2007US20070275075 Ezetimibe compositions
11/29/2007US20070275074 Controlled agglomeration
11/29/2007US20070275073 Clay-based hemostatic agents and devices for the delivery thereof
11/29/2007US20070275072 Butyl lactate emulsions for the precipitation of water-insoluble drug nanoparticles
11/29/2007US20070275071 Use of Microparticles for Antigen Delivery
11/29/2007US20070275070 Barrier film-forming germicidal composition for controlling mastitis
11/29/2007US20070275069 Hydrophobic biomolecular structure
11/29/2007US20070275068 Controlled Release Delivery System for Bio-Active Agents
11/29/2007US20070275067 Compression Coated Tablet Comprising Sumatriptan
11/29/2007US20070275066 Sustained release drug delivery system composed of water insoluble polymer
11/29/2007US20070275065 Controlled release oxycodone compositions
11/29/2007US20070275064 Solid Tablets Composition Rapidly Dissolvable in Water or Watery Liquids and Used for Body, Skin, Hair and Oral Hygiene and Desinfection
11/29/2007US20070275063 Sustained release pharmaceutical compositions and methods of treatment using the same
11/29/2007US20070275062 Use of oral dosage form prepared by forming granules comprising oxycodone hydrochloride, spray-dried lactose, Eudragit (reg), talc and magnesium stearate and drying said granules; improving efficiency and quality of pain management
11/29/2007US20070275061 Pharmaceutical compositions and formulations of metformin extended release tablets
11/29/2007US20070275060 Extended release solid pharmaceutical composition containing carbidopa and levodopa
11/29/2007US20070275059 Flashmelt oral dosage formulation
11/29/2007US20070275058 Tablet Quickly Disintegrating in Oral Cavity
11/29/2007US20070275057 Formulation and Process for the Preparation of Modafinil
11/29/2007US20070275056 Method for treating minor aphthous ulcers
11/29/2007US20070275055 Compositions capable of facilitating penetration across a biological barrier
11/29/2007US20070275054 Novel composition and use
11/29/2007US20070275053 Anti-stick formula delivered by spray process to facilitate swallowing of solid object, such as pill, tablet capsule or caplet.
11/29/2007US20070275052 Pharmaceutical compositions containing sterol inhibitors
11/29/2007US20070275051 Pharmaceutical formulations: salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
11/29/2007US20070275050 Method for treating blood coagulation disorders
11/29/2007US20070275049 Anti-tumor molecular vacine and method of making thereof
11/29/2007US20070275048 Liposome composition for delivery of a therapeutic agent to eyes
11/29/2007US20070275047 Oligonucleotides Related to Lipid Membrane Attachments
11/29/2007US20070275046 Noval Surfactants and Applications Thereof
11/29/2007US20070275045 Composition for the treatment of warts and molluscum contagiosum
11/29/2007US20070275044 Novel drug delivery technology
11/29/2007US20070275041 Tooth whitening strips
11/29/2007US20070275040 Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
11/29/2007US20070275039 Compressed articles with microencapsulation
11/29/2007US20070275035 Minimally Invasive Medical Implant Devices for Controlled Drug Delivery
11/29/2007US20070275030 Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations
11/29/2007US20070275026 Therapeutic Use of a Growth Factor, NsG33
11/29/2007US20070275024 Starch Films and Uses Thereof
11/29/2007US20070274997 Compositions and Methods for Herpes Simplex Prophylaxis and Treatment
11/29/2007US20070274979 Compositions and Methods for Promoting Neuronal Outgrowth
11/29/2007US20070274962 Methods and Composition for Transplantation of Dopaminergic Neurons for Parkinson's Disease
11/29/2007US20070274953 Photochemical internalization for delivery of molecules into the cytosol
11/29/2007US20070274949 Cd25 Dna Vaccines for Treating and Preventing T-Cell Mediated Diseases
11/29/2007US20070274927 Adherent polyol troche
11/29/2007US20070274926 Method of inhibiting the transmission of viruses
11/29/2007US20070274925 Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
11/29/2007US20070274907 Magnetically Targetable Mitomycin C Compositions and Methods of Their Use
11/29/2007US20070272664 Carbon and Metal Nanomaterial Composition and Synthesis
11/29/2007US20070272121 Ready Mix Flavored Film Coating Systems
11/29/2007DE102006024289A1 Partikel Particle
11/29/2007DE102006023756A1 Ethanolhaltige Aerosolformulierung für die Inhalation Ethanol-containing aerosol formulation for inhalation
11/29/2007CA2653786A1 Oral preparation comprising pioglitazone
11/29/2007CA2653124A1 Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
11/29/2007CA2653111A1 Inhalant aerosol formulations containing ethanol
11/29/2007CA2653085A1 Aqueous solution of 20(r)-ginsenoside rg3 pharmaceutical composition and process thereof
11/29/2007CA2652903A1 Process for producing nanoparticles by spray drying
11/29/2007CA2652838A1 Bilayer tablet for preventing cardiovascular events
11/29/2007CA2652751A1 Pharmaceutical compositions and methods of using same
11/29/2007CA2652699A1 Propellant-free inhalation aerosol formulation containing ipratropium bromide and salbutamol sulfate
11/29/2007CA2652697A1 Inhalant propellant-free aerosol formulation
11/29/2007CA2652694A1 Aerosol formulation containing ipratropium bromide and salbutamol sulfate
11/29/2007CA2652573A1 Unit dose formulations comprising an inhalable solution of albuterol
11/29/2007CA2652530A1 Nanoparticles of chitosan and hyaluronan for the administration of active molecules
11/29/2007CA2652362A1 A composition for inactivating an enveloped virus
11/29/2007CA2651451A1 Extended release oral multimicroparticle dosage form
11/29/2007CA2650626A1 Delivery of active agents using a chocolate vehicle
11/29/2007CA2649810A1 Cladribine regimen for treating multiple sclerosis
11/29/2007CA2647563A1 Personal care compositions
11/28/2007EP1859794A1 Sustained release supplements
11/28/2007EP1859792A1 Nanoparticles of chitosan and hyaluronan for the administration of active molecules
11/28/2007EP1859791A1 Sugar-coated pill
11/28/2007EP1859790A2 Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
11/28/2007EP1859789A1 Dosage form that is secured against misuse
11/28/2007EP1859788A1 Production of enveloped pharmaceutical dosage forms
11/28/2007EP1859787A2 Sprinkling method for producing powder formulations
11/28/2007EP1859786A1 A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
11/28/2007EP1858957A1 Polyoxyalkylene-alkyl functional siloxane resins and aqueous compositions thereof
11/28/2007EP1858556A1 Vehicle for topical delivery of anti-inflammatory compounds
11/28/2007EP1858547A1 Immunogenic compositions
11/28/2007EP1858533A2 Use of amniotic fluid (af) in treating ocular disease and injury
11/28/2007EP1858532A1 Compositions and methods for less immunogenic protein formulations
11/28/2007EP1858522A1 Pharmaceutically acceptable carrier for ophthalmic compositions
11/28/2007EP1858517A2 Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
11/28/2007EP1858514A1 Pharmaceutical tablets of crystalline type ii aripiprazole
1 ... 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 ... 2991